US FDA eyes ways to increase transparency
This article was originally published in Scrip
Executive Summary
US FDA commissioner Dr Margaret Hamburg has announced the creation of a task force to develop recommendations for enhancing transparency at the agency, with a report due in six months. The move has the potential to make more information available to doctors, researchers and the public about agency decision-making, but critics contend that secrecy laws could prove to be an impediment.